Is lowering lipoprotein(a) beneficial when LDL-C is very low?Lp(a) as a cardiovascular risk factor – Is lowering Lp(a) beneficial when LDL is low?Low LDL-C and cognitive function: Benefit or harm?Do low LDL-C levels enhance diabetes risk?

Education & Resources

Slides

Evolution of PCSK9 inhibitors: Pipedream or Evidence based Reality

How do we recognize FH in clinical practice?

PCSK9 Inhibitors: A View of Clinical Studies

FH in children and adolescents

ALN-PCSsc: Initial Phase 1 Study Results View all slides »

Videos

Is lowering lipoprotein(a) beneficial when LDL-C is very low?

How best to optimise PCSK9 inhibition, considering findings from FOURIER and ODYSSEY Outcomes

What’s in the PCSK9 pipeline?

EAS Congress: Lowering lipoprotein(a) for clinical benefit: How much?

View all videos »

Events

European Society of Cardiology Congress
Event start date: 25 Aug 2018
Munich, Germany

2018 NLA Scientific Sessions
Event start date: 26 Nov 2018
Las Vegas, USA

View all events »

Guidelines & Consensus Guidance

View all guidelines »

PCSK9 Education and Research Forum is a not-for-profit organisation established by leading researchers in the fields of atherosclerosis, lipids and cardiovascular disease. The PCSK9 Education and Research Forum is focused on raising awareness and knowledge of the significant role played by PCSK9 in lipid metabolism and its value as a novel therapeutic target. As part of its remit, PCSK9 Education and Research Forum offers healthcare professionals open access to electronic and multimedia platforms providing real-time reporting of significant developments and news; authoritative analysis and commentary; as well as an extensive library of accredited educational materials tailored to the differing needs of registrants.

Our Partnership and Outreach

Through its unique global network of researchers and clinicians, the PCSK9 Education and Research Forum connects academic institutions, research organisations and societies which share the Forum’s commitment to the reduction of CVD mortality and morbidity through improved management of atherosclerotic dyslipidaemia. The Forum builds on educational partnerships with such organisations through jointly sponsored symposia, as well as accredited research and educational programmes.

Educational Partners and Supporters

Education & Resources

Slides

Videos

Events

Trials

Links

Press

Guidelines & Consensus Guidance

Archived articles

Find out more

About PCSK9 Education and Research Forum

Our Partnership and Outreach